Search

everythinglearnresearchcommunity

for

Search:↓

Using tamsulosin and finasteride together for benign prostatic syndrome has increased and shows improvement in symptoms, but more reliable comparisons are needed.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Men who start losing hair at 20 may have a higher chance of getting prostate cancer later.

Larger prostate size in older men may be linked to poorer semen quality and fertility issues.

Terazosin hydrochloride helps with BPH and blood pressure, but not more than the control.

Combining D-004 and finasteride is more effective at reducing prostate enlargement than using either alone.

Dutasteride may lower the chance of finding prostate cancer in men with enlarged prostates.

No link between hair loss severity and PSA levels in men.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Flutamide, a medication used for excessive hair growth, can cause severe liver damage in women.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Ultrasonic microneedles improve hair regrowth treatment effectiveness without side effects.

Finasteride effectively treats BPH but requires continuous use to maintain benefits.

Taking dutasteride for one month before prostate surgery can reduce bleeding.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

Wedelolactone selectively kills prostate cancer cells without harming normal cells.

More research and guidelines are needed for managing prostate cancer in people with high-risk genetic mutations.

Kolaviron and quercetin may help treat prostate issues.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Ursolic acid can shrink the prostate and lower a hormone linked to prostate growth in rats.

Cyproterone acetate effectively treats sexual disorders by reducing sexual functions and is generally well-tolerated.

Urologic diseases and treatments in older men can negatively affect fertility, and doctors should talk to patients about this.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Serenoa repens may help with prostate issues, but more research is needed to confirm its effectiveness.